## HUM: Humana Inc. - XLV: Healthcare

### Executive Summary

PARABOLIC warning: MRS_10 at 8.2% exceeds exhaustion threshold (8.0%). Extreme momentum typically precedes mean reversion. Consider profit-taking or tight stops.

- **Horizon:** 1-5 days (momentum)
- **Risk Profile:** High - extreme momentum reversal risk
- **Stop Type:** Fixed 2xATR ($255.52)
- **If Wrong:** Exit on momentum reversal or stop hit
- **Invalidation:** MRS_10 drops below exhaustion threshold

### News

- **Articles:** 10
- **Sentiment:** Bearish (Bullish: 2, Bearish: 4)

**1. Humana Brings In Amazon Healthcare Exec To Lead As Insurance Chief**
- Source: Finimize | 20251216T144907 | Somewhat-Bearish | Relevance: 100%
- Humana has appointed Aaron Martin, former Amazon healthcare VP, as its new president of Medicare Advantage, overseeing the insurance segment after the current president retires next year. This leadership change signals Humana's push for digital transformation amidst rising healthcare costs and competition, though investors remain cautious, causing a slight dip in stock despite profit targets holding steady. The move highlights the broader industry trend of insurers embracing tech-savvy leaders to modernize and manage expenses.

**2. Humana Inc. Announces Executive Changes**
- Source: TradingView â€” Track All Markets | 20251216T131542 | Neutral | Relevance: 100%
- Humana Inc. announced executive changes, with George Renaudin, Insurance Segment President, set to retire by Q3 2026. Aaron Martin will join as President of Medicare Advantage in January 2026 before assuming Renaudin's role, and John Barger will be promoted to President of Medicare Advantage. These changes were detailed in an SEC filing on December 16, 2025.

**3. Humana Announces Insurance Leadership Transition**
- Source: Business Wire | 20251216T130807 | Bullish | Relevance: 100%
- Humana Inc. announced that George Renaudin, Insurance Segment President, will retire by Q3 2026 after 29 years with the company. Aaron Martin will join Humana in January 2026 as President of Medicare Advantage, eventually succeeding Renaudin as Insurance Segment President. John Barger will then be promoted to President of Medicare Advantage, reporting to Martin.

**4. Humana Stock Slips After Naming Former Amazon Executive as Next Insurance President**
- Source: Barron's | 20251216T144407 | Somewhat-Bearish | Relevance: 100%
- Humana's stock fell following the announcement of its current insurance president's retirement and the reiteration of its annual guidance. The company named a former Amazon executive as the new president of its insurance division. This news comes as Humana shares have seen a 15% increase over the past year.

**5. Humana drops as reaffirmed EPS guidance falls short of consensus**
- Source: MSN | 20251216T142407 | Bearish | Relevance: 100%
- Humana's stock fell after the company reaffirmed its prior 2025 earnings per share (EPS) guidance. This guidance, while reiterated, came in below the consensus estimates from analysts, raising investor concerns about future profitability. The market reacted negatively, leading to a drop in the company's share price.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-05 | Jefferies | $313 | $253 | +24% |
| 2025-11-25 | Barclays | $234 | $245 | -4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-05 | Jefferies | up | Buy |
| 2025-11-25 | Barclays | main | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 5 ($0.14M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 57.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 11.8% (-0.3%)
- Dodge & Cox Inc.: 9.4% (-0.1%)
- JPMORGAN CHASE & CO: 8.4% (+237.0%)
- Blackrock Inc.: 8.3% (-3.0%)
- State Street Corpora: 4.5% (-0.2%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Momentum building: MRS_10 improving +8.3% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.06 suggests fair value with growth premium. Balance sheet: strong liquidity (2.0x). Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $33.0B |
| Beta | 0.47 |
| 52W Range | $206.87 - $315.35 |
| Short Interest | 4.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.06 |
| Forward P/E | 21.9 |
| Current P/E | 16.1 |
| YoY Growth | -26.4% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -0.1% to 8.2% (+8.3% in 5 days), confirming momentum buildup. Extended beyond STRENGTH zone (8.2% > 6.0%), caution on chasing. MRS_5 at 5.9% confirms short-term momentum alignment. Outperforming sector by 6.8pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (4.46), confirming momentum. OFD pattern: +MLN (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 8.19% (CS: 98) | Strong |
| RSI_14 | 64.4 | Neutral |
| MACD Histogram | 4.46 | Bullish |
| vs SMA20 | 1.114x | Above |
| vs SMA50 | 1.045x | Above |
| vs SMA200 | 1.062x | Above |

### Decision

- **Verdict:** SELL
- **Thesis:** PARABOLIC

### Trade Setup

- **Entry:** $274.74
- **Stop Loss:** $255.52 (7.0% risk)
- **Target:** $293.96 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** PARABOLIC thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 62
- **Position Value:** $17,033.88
- **Portfolio %:** 17.03%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at moderate levels (16.5) with elevated put/call ratio suggesting cautious positioning, while normal yield curve and stable breadth indicate no systemic stress. Focus on selective opportunities with defensive positioning.*

### Earnings

**Next:** 2026-02-11 (Est: $-3.89)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.83 | $3.24 | +14.6% |
| 2025Q2 | $5.87 | $6.27 | +6.9% |
| 2025Q1 | $10.07 | $11.58 | +15.0% |
| 2024Q4 | $-2.12 | $-2.16 | -1.9% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*